arrow
X

Xiuning Le

md anderson cancer center
H指数:50
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep learning of CT imaging predicts PD-L1 expression and immunotherapy response in metastatic NSCLC: A multi-center study

深度学习CT成像预测转移性NSCLC中PD-L1表达和免疫治疗效果:一项多中心研究

2026-06-190
PRE
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer

MET过表达与晚期非小细胞肺癌中更优的免疫治疗效果相关联

2025-11-270
OAAI
Radiotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer: A Practical Multidisciplinary Approach to Challenging Scenarios from the International Association for the Study of Lung Cancer (IASLC) Advanced Radiation Technology (ART) Subcommittee

不可切除的局部晚期非小细胞肺癌的放射治疗:国际肺癌研究协会(IASLC)高级放射技术(ART)分委会针对挑战性场景的实用多学科方法

2025-11-140
PRE
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients

基于放射组学的动态肺癌风险预测(针对USPSTF非适用人群)

2025-10-230
OAAI
Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report

奥希替尼联合萨沃利替尼治疗在一线奥希替尼治疗后具有MET改变的EGFR突变晚期NSCLC患者:临床结局、安全性和生物标志物分析:简要报告

2025-10-210
PRE
CoCo-ST detects global and local biological structures in spatial transcriptomics datasets

Coco-st检测空间转录组数据集中的全局和局部生物结构

2025-10-130
OA
The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lung Cancer: a Vodcast

II期COPERNICUS研究:皮下注射Amivantamab联合Lazertinib作为一线治疗,或与化疗联合作为二线治疗,用于EGFR突变非小细胞肺癌的播客视频

2025-10-110
OA
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer

Sevabertinib治疗晚期HER2-Mutant非小细胞肺癌

2025-10-014
PRE
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

poziotinib 用于 EGFR 外显子 20 插入型 NSCLC:ZENITH II 期试验的临床疗效及 EGFR 外显子 20 插入位点对敏感性的差异化影响

2025-09-240
OAAI
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

机器学习驱动的转移性非小细胞肺癌免疫治疗适应性策略

2025-07-240
OAAI
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model

利用Brock模型和Sybil模型对持续性肺结节患者进行肺癌风险评估

CANCERS
IF4.4
2025-04-290
OA
Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series

Tepotinib联合EGFR酪氨酸激酶抑制剂在EGFR突变、MET改变的NSCLC患者中的应用:一项病例系列研究

2025-02-210
PRE
Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA
2025-01-010
PRE